📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Intracellular-signaling tumor-regression modeling of the pro-apoptotic receptor agonists dulanermin and conatumumab (2012)

First Author: Kay B

Attributed to: How does nuclear shell structure evolve with neutron excess? Using next generation radioactive ion beams facilities to explore exotic nuclei. funded by STFC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10928-012-9269-x

PubMed Identifier: 22932917

Publication URI: http://europepmc.org/abstract/MED/22932917

Type: Journal Article/Review

Parent Publication: Journal of Pharmacokinetics and Pharmacodynamics

Issue: 5

ISSN: 1567-567X